Covidence vs Silvi
Covidence scores 4.1 to Silvi's 3.6 among the systematic review platforms we rate, and is the better pick for 2 of the 5 kinds of buyer below.
Covidence wins, 4.1 to 3.6
Covidence costs $339 a year; Silvi's cheapest paid plan, Rapid, is 40 euros a month. Both only import references you already found elsewhere rather than searching a paper database themselves. Covidence includes AI assisted screening and unlimited collaborators from its cheapest plan, while Silvi holds AI screening back until Rapid and only adds team collaboration on the pricier Rapid Plus plan at 59 euros a month. Silvi does have a browser extension, which Covidence lacks.
Pick Covidence if you want AI screening and unlimited collaborators from the start.
Pick Silvi if you want a browser extension and don't need collaboration yet.
Best for
Who each one suits, decided on the criteria that matter to that buyer and the checked facts where the two differ.
- Answers show the passage they came from: Silvi yes, Covidence no
- AI help with screening: Covidence yes, Silvi no
- University or library licence: Covidence yes, Silvi no
- Works with Zotero, Mendeley, EndNote and others: EndNote, Zotero, RefWorks, Mendeley, RevMan, CRS against Zotero
- Export formats: RIS, CSV, PubMedXML against CSV, Excel
- But Silvi leads on browser extension: Silvi yes, Covidence no
How they score
Both are scored the same way, against the other systematic review platforms we rate, from facts on each vendor's own pages. Covidence leads on 4 of 6 criteria.
Where they differ
Every point where the two vendors' published facts disagree, with a link to where each fact was read. "Not published" means the vendor does not say either way.
Published by only one of them
Where they match (21)
Pricing, plan by plan
Every plan each vendor publishes, monthly and yearly where both are offered.
Covidence
Silvi
Pros and cons
From each tool's full review, written from the same checked facts.
Covidence
- Purpose-built for systematic reviews and evidence synthesis, making it highly optimized for that specific academic and clinical workflow.
- Supports unlimited collaborators on every plan, enabling large research teams to work together without user-count penalties.
- Title and abstract screening interface is fast and well-designed, reducing friction in the most time-consuming part of the review process.
- Mobile browser screening is supported, allowing co-reviewers to contribute while traveling or away from their desks.
- Trusted by over 536,000 researchers and students across more than 480 universities and hospitals, indicating strong real-world validation.
- Supports multiple import formats including RIS, CSV, and PubMedXML, making it compatible with major reference databases like PubMed.
- Conflict resolution tools are built into the screening workflow, helping teams manage disagreements systematically and according to protocol.
- No native search functionality — users must import references from external databases before any work can begin in the platform.
- AI features do not meet modern expectations, which may disappoint researchers looking for intelligent automation or AI-assisted synthesis.
- Solo reviewer pricing starts at $339 per year, which is a significant cost for individual academics or students without institutional backing.
- The tool is not useful outside of systematic review workflows, making it a poor fit for general-purpose research or literature exploration.
- Pricing and product design clearly favor institutional users, meaning solo or small-team reviewers may feel like second-class customers.
- Relies on external tools like RevMan for final output, so it does not offer an end-to-end standalone solution for evidence synthesis.
Silvi
- Built specifically for systematic literature reviews, covering the full review pipeline from search to data extraction and synthesis.
- Database imports from PubMed, OpenAlex, and ERIC are supported, though search happens on each database's own site before importing into Silvi; Zotero import is also supported.
- PDF highlighting system automatically stores both extracted data and source location, providing full traceability essential for rigorous systematic reviews.
- AI screening and data extraction tools operate in a human-in-the-loop model, letting researchers validate and correct suggestions rather than being locked into automated decisions.
- Collaboration features include task assignment, blinding, and conflict resolution between reviewers — methodologically meaningful, not just surface-level.
- Positioned as a more affordable alternative to Covidence while covering comparable systematic review workflow stages.
- Web-based interface is clean and modern, avoiding the dated UX associated with older academic research tools.
- No mobile app, limiting flexibility for researchers whose workflow moves across devices or contexts.
- Relatively niche tool with limited user feedback and community discussion, making it harder to assess real-world reliability at scale.
- Database coverage, while solid, does not include every source academic researchers may need for comprehensive systematic reviews.
- As a smaller Copenhagen-based tool, long-term support, development roadmap, and enterprise reliability are less proven than established competitors.
- Limited public user reviews make it difficult to verify how well AI screening accuracy holds up across different research domains.
- The tool's niche focus means it is not suitable for general AI research, note-taking, or broader literature management tasks.
Covidence vs Silvi: common questions
Which is better, Covidence or Silvi?
Covidence scores 4.1 and Silvi 3.6 out of 10 among the systematic review platforms we rate. Covidence is ahead on systematic reviews, pricing, citing and writing and access, teams and privacy. Silvi is ahead on reading and analysing papers.
Is Covidence or Silvi cheaper?
Covidence's cheapest paid plan is $339/year and Silvi's is €40/mo (billed monthly; €19/mo billed annually). Compare what each plan includes below before going on price alone.
What can Covidence do that Silvi cannot?
On the facts both vendors publish: aI help with screening and university or library licence.
What can Silvi do that Covidence cannot?
On the facts both vendors publish: answers show the passage they came from and browser extension.
